| Survival: | 9.3 months |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy Immunotherapy |
| Drugs: | Adriamycin Platinol |
| Country: | Italy |
| City/State/Province: | Milano |
| Hospital: | Istituto Clinico Humanitas |
| Journal: | Link |
| Date: | 8/2001 |
| Description: |
| Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before. Treatment: The treatment consisted of the chemotherapy drugs cisplatin (platinol) and doxorubicin (adriamycin) with alpha-2b interferon. Toxicity: Grade 4 toxicities included hematologic and renal. Results: The median survival was 9.3 months. Correspondence: Hector Soto Parra |